These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 9121087)
21. [Cardiac abnormalities in antiphospholipid syndrome]. Meng XM; Zhao Y; Fang LG; Yan XW Zhonghua Nei Ke Za Zhi; 2007 Apr; 46(4):284-6. PubMed ID: 17637264 [TBL] [Abstract][Full Text] [Related]
22. [Cardiac abnormalities in systemic lupus erythematosus and their association with antiphospholipid antibodies]. Laganà B Recenti Prog Med; 1993 Oct; 84(10):662-72. PubMed ID: 8235032 [TBL] [Abstract][Full Text] [Related]
23. Valvular heart disease in the primary antiphospholipid syndrome. Galve E; Ordi J; Barquinero J; Evangelista A; Vilardell M; Soler-Soler J Ann Intern Med; 1992 Feb; 116(4):293-8. PubMed ID: 1733383 [TBL] [Abstract][Full Text] [Related]
24. Cardiac manifestations of the antiphospholipid antibody syndrome: a review. Nayak AK; Komatireddy G Mo Med; 2002 Apr; 99(4):171-8. PubMed ID: 11977483 [TBL] [Abstract][Full Text] [Related]
26. [Anti-endothelial antibodies and defects of heart valves in antiphospholipid syndrome: analysis of pathogenic mechanisms]. Nasonov EL; Salozhin KV; Fomicheva OA; Kliukvina NG; Karpov IA; Vil'chinskaia MI; Aleksandrova EN; Alekberova ZS; Baranov AA; Sergakova LM; Kotel'nikova GP; Le Tonqueze M; Nasonova VA; Youinou P Klin Med (Mosk); 1997; 75(2):17-22. PubMed ID: 9157207 [No Abstract] [Full Text] [Related]
27. [Prevalence and description of cardiac involvements in primary antiphospholipid syndrome]. Derumeaux G; Lenormand C; Borg JY; Lévesque H; Tron F; Letac B Arch Mal Coeur Vaiss; 1992 Dec; 85(12):1811-8. PubMed ID: 1306623 [TBL] [Abstract][Full Text] [Related]
28. Valvular lesions in patients with systemic lupus erythematosus and antiphospholipid syndrome: an old disease but a persistent challenge. Ferreira E; Bettencourt PM; Moura LM Rev Port Cardiol; 2012 Apr; 31(4):295-9. PubMed ID: 22386150 [TBL] [Abstract][Full Text] [Related]
35. Preliminary classification criteria for the antiphospholipid syndrome within systemic lupus erythematosus. Alarcón-Segovia D; Pérez-Vázquez ME; Villa AR; Drenkard C; Cabiedes J Semin Arthritis Rheum; 1992 Apr; 21(5):275-86. PubMed ID: 1604324 [TBL] [Abstract][Full Text] [Related]
36. Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-beta 2-glycoprotein-I than with antiphospholipid antibodies. Cabiedes J; Cabral AR; Alarcón-Segovia D J Rheumatol; 1995 Oct; 22(10):1899-906. PubMed ID: 8991989 [TBL] [Abstract][Full Text] [Related]
37. [Heart valve involvement in systemic lupus erythematosus: an echocardiographic study]. Marcon C; Moro E; Sforza P; Piccoli G; Maresca MC; Adami A G Ital Cardiol; 1992 Nov; 22(11):1301-8. PubMed ID: 1297616 [TBL] [Abstract][Full Text] [Related]
38. The antiphospholipid/cofactor syndromes. II. A variant in patients with systemic lupus erythematosus with antibodies to beta 2-glycoprotein I but no antibodies detectable in standard antiphospholipid assays. Alarcon-Segovia D; Mestanza M; Cabiedes J; Cabral AR J Rheumatol; 1997 Aug; 24(8):1545-51. PubMed ID: 9263149 [TBL] [Abstract][Full Text] [Related]